Influence of PTGS1 gene polymorphisms on efficiency and safety of post-operative Ketorolac treatment of uncomplicated acute calculus cholecystitis

Abstract

Objective : The study aimed to evaluate the possible association of PTGS1 gene polymorphisms (rs10306135, rs12353214) with the clinical effi cacy and safety of ketorolac in relation to postoperative pain. Materials and methods : The study included 107 patients after video laparoscopic cholecystectomy, who received ketorolac 30 mg as postoperative pain relief 2.0 x 3 times a day. All patients were genotyped for PTGS1 (rs10306135, rs12353214). The pain syndrome was assessed using the Visual Analog scale (VAS), the McGill pain questionnaire. The profi le of adverse reactions was assessed by the dynamics of red blood counts, as a possible trigger for the development of gastrointestinal bleeding according to the method of global assessment of triggers (GTT). Results : According to the VAS and the McGill pain questionnaire, there were no statistically signifi cant diff erences in the intensity of pain between the two groups. There were also no statistically signifi cant diff erences in the dynamics of red blood counts. Conclusion : We did not fi nd an association between the carriage of the PTGS1 genotype (rs10306135, rs12353214) and the effectiveness of postoperative anesthesia with ketorolac, and we did not fi nd an association with the risk of developing adverse reactions after ketorolac anesthesia.